Simplex Trading
PCVX icon

Simplex Trading’s Vaxcyte PCVX Stock Holding History

Simplex Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.76M Sell
101,200
-400
-0.4% -$23.3K ﹤0.01% 1085
2026
Q2 		$5.91M Buy
101,600
+56,900
+127% +$3.09M ﹤0.01% 1094
2026
Q1 		$2.6M Buy
44,700
+38,300
+598% +$2.08M ﹤0.01% 1605
2025
Q4 		$295K Buy
6,400
+4,800
+300% +$215K ﹤0.01% 3832
2025
Q3 		$57K Buy
1,600
+400
+33% +$13.3K ﹤0.01% 6322
2025
Q2 		$39K Buy
1,200
+400
+50% +$13.1K ﹤0.01% 6172
2025
Q1 		$30K Sell
800
-23,100
-97% -$1.85M ﹤0.01% 6248
2024
Q4 		$1.96M Sell
23,900
-39,500
-62% -$3.92M ﹤0.01% 2212
2024
Q3 		$7.24M Buy
63,400
+63,000
+15,750% +$5.68M ﹤0.01% 1240
2024
Q2 		$30K Sell
400
-800
-67% -$54.5K ﹤0.01% 6566
2024
Q1 		$81K Buy
1,200
+1,100
+1,100% +$76.2K ﹤0.01% 5800
2023
Q4 		$6K Sell
100
-300
-75% -$15.6K ﹤0.01% 7776
2023
Q3 		$20K Sell
400
-25,700
-98% -$1.27M ﹤0.01% 6629
2023
Q2 		$1.3M Buy
26,100
+23,700
+988% +$1.12M ﹤0.01% 2351
2023
Q1 		$89K Sell
2,400
-41,000
-94% -$1.74M ﹤0.01% 5283
2022
Q4 		$2.08M Buy
+43,400
New +$1.7M ﹤0.01% 1831
2022
Q3 		– Sell
-200
Closed -$4K – 10638
2022
Q2 		$4K Buy
+200
New +$4.63K ﹤0.01% 9013
2021
Q2 		– Sell
-1
Closed -$1K – 10537
2021
Q1 		$1K Buy
+1
New +$25 ﹤0.01% 8574

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Simplex Trading's PCVX Position: Q3 2026 in Review

Simplex Trading opened a new position in Vaxcyte (PCVX) in Q3 2026: 133 shares worth $7.57K. The stake represents ﹤0.01% of the portfolio and ranks #7825 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCVX as recently as Q4 2025.

Simplex Trading first reported a position in PCVX in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2024. 167 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Simplex Trading held 133 shares of Vaxcyte worth $7.57K as of Q3 2026.
  • Vaxcyte was a new Simplex Trading position in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7825 holding.
  • Simplex Trading first reported a position in Vaxcyte in Q2 2022 and has held it in 7 quarters since.
  • Simplex Trading's Vaxcyte position peaked at $1.05M in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.